The NEO-CYT study, sponsored by Fondazione Melanoma Onlus, will be evaluating MDNA11 in front-line therapy for resectable advanced cutaneous melanoma with patient enrolment planned to commence in H1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback